BackMedigus Ltd. - Warrants Overview

Medigus Ltd. - Warrants Total Liabilities

Track Medigus Ltd. - Warrants's total liabilities ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$31.46M
26.77% YoYΔ $-11.50M vs prior year quarter

Peer average

Loading

Medigus Ltd. - Warrants Total Liabilities History

Loading

Medigus Ltd. - Warrants vs. peers: Total Liabilities Comparison

Loading

Medigus Ltd. - Warrants Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Medigus Ltd. - Warrants (MDGSW) FAQ

Medigus Ltd. - Warrants's total liabilities stands at $31M as of December 2023. That compares with $43M in the prior-year period — down 26.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Medigus Ltd. - Warrants reported $31M in total liabilities versus $43M a year earlier — a 26.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $43M in the prior-year period — down 26.8% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Medigus Ltd. - Warrants's total liabilities evolved across reporting periods, while the comparison chart places MDGSW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. Medigus Ltd. - Warrants's reading of $31M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.